Jiangsu Jibeier Pharmaceutical Co., Ltd. (SHA:688566)
China
· Delayed Price · Currency is CNY 28.00
+0.04 (0.14%)
Apr 30, 2026, 2:55 PM CST
SHA:688566 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 253.46 | 261 | 219.33 | 219.09 | 154.67 | 114.9 | Upgrade
|
| Depreciation & Amortization | 17.77 | 17.77 | 10.6 | 11.2 | 12.75 | 12.98 | Upgrade
|
| Other Amortization | 0.69 | 0.69 | 0.89 | 1.07 | 1.09 | 1.09 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | 0.01 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.01 | 0.01 | 42.24 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.81 | 0.81 | -1.39 | 0.48 | -5.68 | -17.26 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | 2.26 | 7.2 | 0.73 | -1.77 | Upgrade
|
| Other Operating Activities | -62.12 | -3.69 | -0.59 | 1.81 | -0.4 | -0.55 | Upgrade
|
| Change in Accounts Receivable | -61 | -61 | -24.28 | -138.14 | -72.08 | 42.96 | Upgrade
|
| Change in Inventory | 3.61 | 3.61 | -1.19 | 1.12 | -0.83 | 0.28 | Upgrade
|
| Change in Accounts Payable | 11.58 | 11.58 | -37.6 | 38.47 | 39.43 | -8.6 | Upgrade
|
| Change in Other Net Operating Assets | 23.03 | 23.03 | 6.81 | 17.89 | 21.51 | 7.33 | Upgrade
|
| Operating Cash Flow | 182.34 | 248.3 | 215.29 | 159.5 | 150.72 | 150.56 | Upgrade
|
| Operating Cash Flow Growth | 2.79% | 15.33% | 34.98% | 5.82% | 0.11% | 28.28% | Upgrade
|
| Capital Expenditures | -111.35 | -114.6 | -174.53 | -357.37 | -292.7 | -83.79 | Upgrade
|
| Sale of Property, Plant & Equipment | 0 | 0 | - | - | 0.01 | 0 | Upgrade
|
| Cash Acquisitions | -20.38 | -20.38 | - | - | - | - | Upgrade
|
| Investment in Securities | -5 | -10 | -51 | -15 | 108.8 | -270 | Upgrade
|
| Other Investing Activities | 67.8 | -129.6 | 5.36 | 8.33 | 8.41 | 20.64 | Upgrade
|
| Investing Cash Flow | -68.92 | -274.57 | -220.17 | -364.04 | -175.49 | -333.15 | Upgrade
|
| Short-Term Debt Issued | - | - | 39.26 | 19.74 | - | - | Upgrade
|
| Total Debt Issued | - | - | 39.26 | 19.74 | - | - | Upgrade
|
| Total Debt Repaid | -2.2 | - | - | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -2.2 | - | 39.26 | 19.74 | - | - | Upgrade
|
| Issuance of Common Stock | - | - | 222.29 | 24.29 | - | - | Upgrade
|
| Common Dividends Paid | -103.71 | -103.7 | -102.95 | -44.87 | -89.73 | -89.73 | Upgrade
|
| Other Financing Activities | 52.59 | 63.85 | -1.31 | -0.4 | - | - | Upgrade
|
| Financing Cash Flow | -53.32 | -39.86 | 157.3 | -1.23 | -89.73 | -89.73 | Upgrade
|
| Net Cash Flow | 60.1 | -66.13 | 152.42 | -205.77 | -114.5 | -272.32 | Upgrade
|
| Free Cash Flow | 70.99 | 133.71 | 40.76 | -197.87 | -141.98 | 66.77 | Upgrade
|
| Free Cash Flow Growth | 306.03% | 228.01% | - | - | - | -28.73% | Upgrade
|
| Free Cash Flow Margin | 7.17% | 13.84% | 4.55% | -22.98% | -21.68% | 13.10% | Upgrade
|
| Free Cash Flow Per Share | 0.35 | 0.67 | 0.21 | -1.06 | -0.76 | 0.35 | Upgrade
|
| Cash Income Tax Paid | 167.44 | 152.97 | 141.42 | 93.83 | 83.36 | 83.52 | Upgrade
|
| Levered Free Cash Flow | -46.33 | 20.19 | -12.08 | -303.05 | -187.73 | 85.4 | Upgrade
|
| Unlevered Free Cash Flow | -46.33 | 20.19 | -12 | -302.99 | -187.5 | 85.4 | Upgrade
|
| Change in Working Capital | -28.28 | -28.28 | -58.05 | -81.35 | -12.44 | 41.18 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.